cAMP and protein kinase A in endocrine (and other) tumors

References

• Robison GA. The biological role of cyclic AMP: an update review. In: Prostaglandins and Cyclic AMP: Biological Actions and Clinical Applications. Kahn RH, Lands WEM (Eds). Academic Press, NY, USA 229–247 (1973).
   Google Scholar
• Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol.2, 599–609 (2001).
   PubMed Web of Science ®Google Scholar
• Conkright MD, Guzman E, Flechner L, Su AI, Hogenesch JB, Montminy M. Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol. Cell11, 1101–1108 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang X, Odom DT, Koo SH et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl Acad. Sci. USA102, 4459–4464 (2005).
   PubMed Web of Science ®Google Scholar
• Dodge-Kafka KL, Soughayer J, Pare GC et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature437, 574–578 (2005).
   PubMed Web of Science ®Google Scholar
• Kopperud R, Krakstad C, Selheim F, Døskeland SO. cAMP effector mechanisms. Novel twists for an ‘old’ signaling system. FEBS Lett.546, 121–126 (2003).
   PubMed Web of Science ®Google Scholar
• Gross-Langenhoff M, Hofbauer K, Weber J, Schultz A, Schultz JE. cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11. J. Biol. Chem.281, 2841–2846 (2006).
   PubMed Web of Science ®Google Scholar
• Kuo JF, Greengard P. Cyclic nucleotide-dependent kinases. IV. Widespread occurrence of adenosine 3´:5´-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom. Proc. Natl Acad. Sci. USA64, 1349–1355 (1969).
   PubMed Web of Science ®Google Scholar
• Beebe SJ, Corbin JD. Cyclic nucleotide-dependent protein kinases. In: The Enzymes: Control by Phosphorylation, Part A. Boyer PD, Krebs EG (Eds). Academic Press, NY, USA 17, 43–111 (1986).
   Google Scholar
• Corbin JD, Keely SL, Park CR. The distribution and dissociation of cyclic adenosine 3´:5´-monophosphate dependent protein kinases in adipose, cardiac, and other tissues. J. Biol. Chem.250, 218–225 (1975).
   PubMed Web of Science ®Google Scholar
• Kurten RC, Levy LO, Shey J Durica JM, Richards JS. Identification and characterization of the GC-rich and cyclic adenosine 3´,5´-monophosphate (cAMP)-inducible promoter of the type II β cAMP dependent protein kinase regulatory subunit gene. Mol. Endocrinol.6, 536–550 (1992).
   PubMedGoogle Scholar
• Nowak I, Seipel K, Schwartz M, Jans DA, Hemmings BA. Isolation of cDNA and characterization of the 5´ flanking region of the gene encoding the type I regulatory subunit of the cAMP-dependent protein kinase. Eur. J. Biochem.167, 27–33 (1987).
   PubMedGoogle Scholar
• Dostmann WR, Taylor SS, Genieser HG, Jastorff B, Døskeland SO, Ogreid D. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3´,5´-cyclic phosphorothioates. J. Biol. Chem.265, 10484–10491 (1990).
   PubMed Web of Science ®Google Scholar
• Hofmann F. Apparent constants for the interaction of regulatory and catalytic subunit of cAMP-dependent protein kinase I and II. J. Biol. Chem.255, 1559–1564 (1980).
   PubMed Web of Science ®Google Scholar
• Vigil D, Blumenthal DK, Brown S et al. Differential effects of substrate on type I and type II PKA holoenzyme dissociation. Biochemistry43, 5629–5636 (2004).
   PubMed Web of Science ®Google Scholar
• Kim C, Xuong NH, Taylor SS. Crystal structure of a complex between the catalytic and regulatory (RIα) subunits of PKA. Science307, 690–696 (2005).
   PubMed Web of Science ®Google Scholar
• Scott JD, McCartney S. Localization of A-kinase through anchoring proteins. Mol. Endocrinol.8, 5–11 (1994).
   PubMedGoogle Scholar
• Kondrashin AA, Nesterova MV, Cho-Chung YS. Subcellular distribution of the R-subunits of cAMP-dependent protein kinase in LS-174T human colon carcinoma cells. Biochem. Mol. Biol. Intern.45, 237–244 (1998).
   PubMedGoogle Scholar
• Imazumi-Scherrer T, Faust DM, Barradeau S, Hellio R, Weiss MC. Type I protein kinase A is localized to interphase microtubules and strongly associated with the mitotic spindle. Exp. Cell Res.264, 250–265 (2001).
   PubMed Web of Science ®Google Scholar
• Carlson CR, Witczak O, Vossebein L et al. CDK1-mediated phosphorylation of the RIIα regulatory subunit of PKA works as a molecular switch that promotes dissociation of RIIα from centrosomes at mitosis. J. Cell. Sci.114, 3243–3254 (2001).
   PubMed Web of Science ®Google Scholar
• Riabowol KT, Fink JS, Oilman MZ, Walsh DA, Goodman RH, Feramisco JR. The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature336, 83–86 (1988).
   PubMed Web of Science ®Google Scholar
• Solberg R, Tasken K, Wen W et al. Human regulatory subunit RIβ of cAMP-dependent protein kinases: expression, holoenzyme formation and microinjection into living cells. Exp. Cell Res.214, 595–605 (1994).
   PubMed Web of Science ®Google Scholar
• Neary CL, Cho-Chung YS. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIα regulatory subunit. Oncogene20, 8019–8024 (2001).
   PubMed Web of Science ®Google Scholar
• Constantinescu A, Wu M, Asher O, Diamond I. cAMP-dependent protein kinase type I regulates ethanol-induced cAMP response element-mediated gene expression via activation of CREB-binding protein and inhibition of MAPK. J. Biol. Chem.279, 43321–43329 (2004).
   PubMed Web of Science ®Google Scholar
• Feliciello A, Giuliano P, Porcellini A et al. The v-Ki-Ras oncogene alters cAMP nuclear signaling by regulating the location and the expression of cAMP-dependent protein kinase IIβ. J. Biol. Chem.271, 25350–25359 (1996).
   PubMed Web of Science ®Google Scholar
• Hofmann F, Bechtel PJ, Krebs EG. Concentrations of cyclic AMP-dependent protein kinase subunits in various tissues. J. Biol. Chem.252, 1441–1447 (1977).
   PubMed Web of Science ®Google Scholar
• Uhler MD, McKnight GS. Expression of cDNAs for two isoforms of the catalytic subunit of cAMP-dependent protein kinase. J. Biol. Chem.262, 15202–15207 (1987).
   PubMed Web of Science ®Google Scholar
• Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS. Genetically lean mice result from targeted disruption of the RII β subunit of protein kinase A. Nature382, 622–626 (1996).
   PubMed Web of Science ®Google Scholar
• Schreyer SA, Cummings DE, McKnight GS, LeBoeuf RC. Mutation of the RII β subunit of protein kinase A prevents diet-induced insulin resistance and dyslipidemia in mice. Diabetes50, 2555–2562 (2001).
   PubMed Web of Science ®Google Scholar
• Planas JV, Cummings DE, Idzerda RL, McKnight GS. Mutation of the RII β subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue. J. Biol. Chem.274, 36281–36287 (1999).
   PubMed Web of Science ®Google Scholar
• Brandon EP, Logue SF, Adams MR et al. Defective motor behavior and neural gene expression in RIIβ-protein kinase A mutant mice. J. Neurosci.18, 3639–3649 (1998).
   PubMed Web of Science ®Google Scholar
• Adams MR, Brandon EP, Chartoff E, Idzerda RL, Dorsa DM, McKnight GS. Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. Proc. Natl Acad. Sci. USA94, 12157–12161 (1997).
   PubMed Web of Science ®Google Scholar
• Amieux PS, Cummings DE, Motamed K et al. Compensatory regulation of RI α protein levels in protein kinase A mutant mice. J. Biol. Chem.272, 3993–3998 (1997).
   PubMed Web of Science ®Google Scholar
• Burton KA, Johnson BD, Hausken ZE et al. Type II regulatory subunits are not required for the anchoring-dependent modulation of Ca2+ channel activity by cAMP-dependent protein kinase. Proc. Natl Acad. Sci. USA94, 11067–11072 (1997).
   PubMed Web of Science ®Google Scholar
• Burton KA, Treash-Osio B, Muller CH et al. Deletion of type II α regulatory subunit delocalizes protein kinase A in mouse sperm without affecting motility or fertilization. J. Biol. Chem.274, 24131–24136 (1999).
   PubMed Web of Science ®Google Scholar
• Skalhegg BS, Johansen AK, Levy FO et al. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines. Levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines. J. Cell Physiol.177, 85–93 (1998).
   PubMed Web of Science ®Google Scholar
• Schuller HM. Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog. Exp. Tumor Res.39, 45–63 (2007).
   PubMed Web of Science ®Google Scholar
• Cho-Chung YS. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res.50, 7093–7100 (1990).
   PubMed Web of Science ®Google Scholar
• Boynton AL, Whietfield JF. The role of cyclic AMP in cell proliferation: a critical assessment of the evidence. In: Advances in Cyclic Nucleotide Research. Greengard P, Robinson GA (Eds). Raven Press, NY, USA 15, 193–294 (1983).
   Google Scholar
• Russell DH. Type I cyclic AMP-dependent protein kinase as a positive effector of growth. In: Advances in Cyclic Nucleotide Research. Greengard P, Robinson GA (Eds). Raven Press, NY, USA 9, 493–506 (1978).
   Google Scholar
• Cho-Chung YS, Nesterova MV, Pepe S et al. Antisense DNA-targeting protein kinase A-RIa subunit: a novel approach to cancer treatment. Front. Biosci.4, D898–D907 (1990).
   Google Scholar
• Amieux PS, McKnight GS. The Essential Role of RIα in the maintenance of regulated PKA activity. Ann. NY Acad. Sci.968, 75–95 (2002).
   PubMed Web of Science ®Google Scholar
• Fossberg TM, Doskeland SO, Ueland PM. Protein kinases in human renal cell carcinoma and renal cortex. A comparison of isozyme distribution and of responsiveness to adenosine 3´,5´-cyclic monophosphate. Arch. Biochem. Biophys.189, 372–381 (1978).
   Web of Science ®Google Scholar
• Handshin JC, Handloser K Takahashi A, Eppenberger U. Cyclic adenosine 3´,5´-monophosphate receptor proteins in dysplastic and neoplastic human breast tissue cytosol and their inverse relationship with estrogen receptors. Cancer Res.43, 2947–2954 (1983).
   PubMed Web of Science ®Google Scholar
• Miller WR. Regulatory subunits of PKA and breast cancer. Ann. NY Acad. Sci.968, 37–48 (2002).
   PubMed Web of Science ®Google Scholar
• Neary CL, Nesterova M, Cho YS, Cheadle C, Becker KG, Cho-Chung YS. Protein kinase A isozyme switching-eliciting differential cAMP signaling and tumor reversion. Oncogene23, 8847–8856 (2004).
   PubMed Web of Science ®Google Scholar
• Cho YS, Kim M-K, Cheadle C, Neary C, Becker KG, Cho-Chung YS. Antisense DNAs as multisite genomic modulators identified by DNA microarray. Proc. Natl Acad. Sci. USA98, 9819–9823 (2001).
   PubMed Web of Science ®Google Scholar
• Cho-Chung YS, Nesterova M, Park YG, Lee YN. Protein kinase A-RIα antisense: antitumor machanism of action. Antisense Nucleic Acid Drug Dev.9, 383–388 (1999).
   Google Scholar
• Alper O, Hacker NF, Cho-Chung YS. Protein kinase A-Iα subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway. Oncogene18, 4999–5004 (1999).
   PubMed Web of Science ®Google Scholar
• Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol.18, 3509–3517 (1998).
   PubMed Web of Science ®Google Scholar
• Cho YS, Kim MK, Tan L et al. Protein kinase A RIα antisense inhibition of PC3M prostate cancer cell growth: bcl-2 hyperphosphorylation, Bax up-regulation, and Bad hypophosphorylation. Clin. Cancer Res.8, 607–614 (2002).
   PubMed Web of Science ®Google Scholar
• Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with Carney complex. Hum. Mol. Genet.9, 3037–3046 (2000).
   PubMed Web of Science ®Google Scholar
• Kirschner LS, Carney JA, Pack SD et al. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the carney complex. Nat. Genet.26, 89–92 (2000).
   PubMed Web of Science ®Google Scholar
• Stratakis CA, Kirshner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J. Clin. Endocrinol. Metab.86, 4041–4046 (2001).
   PubMed Web of Science ®Google Scholar
• Stratakis CA. Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes. Front. Biosci.5, 353–366 (2000).
   Google Scholar
• Groussin L, Kirschner LS, Vincent-Dejean C et al. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am. J. Hum. Genet.71, 1433–42 (2002).
   PubMed Web of Science ®Google Scholar
• Robinson-White A, Stratakis CA. Protein kinase A signaling: “cross-talk” with other pathways in endocrine cells. Ann. NY Acad Sci.968, 256–270 (2002).
   PubMed Web of Science ®Google Scholar
• Robinson-White A, Hundley TR, Shiferaw M et al. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. Hum. Mol. Genet.12, 1475–1484 (2003).
   PubMed Web of Science ®Google Scholar
• Robinson-White A, Meoli E, Stergiopoulos S et al. PRKAR1A mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex. J. Clin. Endocrinol. Metab.91, 2380–2388 (2006).
   PubMed Web of Science ®Google Scholar
• Robinson-White AJ, Leitner WW, Aleem E, Kaldis P, Bossis I, Stratakis CA. PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes. Cancer Res.66, 10603–10612 (2006).
   PubMed Web of Science ®Google Scholar
• Martin NP, Whalen EJ, Zamah MA, Pierce KL, Lefkowitz RJ. PKA-mediated phosphorylation of the β1-adrenergic receptor promoters Gs/Gi switching. Cell Signal.16, 1397–1403 (2004).
   PubMed Web of Science ®Google Scholar
• EL, MM, MC, TM, TT, HMS: NNK activates ERK1/2 and CREB/ATF-1 via β-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. Int. J. Cancer.119, 1547–1552 (2006).
   PubMed Web of Science ®Google Scholar
• Horvath A, Boikos S, Giatzakis C et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat. Genet.38, 794–800 (2006).
   PubMed Web of Science ®Google Scholar
• Horvath A, Giatzakis C, Robinson-White A et al. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res.15, 66, 11571–11575 (2006).
   Google Scholar
• Matyakhina L, Pack S, Kirshner LS et al. Chromosome 2 (2p16) abnormalities in Carney complex tumors. J. Med. Genet.40, 268–277 (2003).
   PubMed Web of Science ®Google Scholar
• Imaizumi-Scherrer T, Faust DM, Barradeau S, Hellio R, Weiss MC. Type I protein kinase A is localized to interphase microtubules and strongly associated with the mitotic spindle. Exp. Cell Res.264, 250–265 (2001).
   PubMed Web of Science ®Google Scholar
• Gupte RS, Weng Y, Liu L, Lee MY. The second subunit of the replication factor C complex (RFC40) and the regulatory subunit (RIα) of protein kinase A form a protein complex promoting cell survival. Cell Cycle4, 323–329 (2005).
   PubMed Web of Science ®Google Scholar
• Gupte RS, Traganos F, Darzynkiewicz Z, Lee MY. Phosphorylation of RIα by cyclin-dependent kinase CDK 2/cyclin E modulates the dissociation of the RIα–RFC40 complex. Cell Cycle5, 653–660 (2006).
   PubMed Web of Science ®Google Scholar
• Gupte RS, Sampson V, Traganos F, Darzynkiewicz Z, Lee MY. Cyclic AMP regulates the expression and nuclear translocation of RFC40 in MCF7 cells. Exp. Cell Res.312, 796–806 (2006).
   PubMed Web of Science ®Google Scholar
• Yang WL, Iacono L, Tang WM, Chin KV. A novel mechanism of cAMP signaling through the interaction of the regulatory subunit of protein kinase A with cytochrome c oxidase subunit Vb. Biochemistry37, 14175–14180 (1998).
   PubMed Web of Science ®Google Scholar
• Liu J, Rone MB, Papadopoulos V. Protein–protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J. Biol. Chem.281, 38879–38893 (2006).
   PubMed Web of Science ®Google Scholar
• Ciardiello F, Tortora G. Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications. Clin. Cancer Res.4, 821–828 (1998).
   PubMed Web of Science ®Google Scholar
• Liguori L, de Lamirande E, Minelli A, Gagnon C. Various protein kinases regulate human sperm acrosome reaction and the associated phosphorylation of Tyr residues and of the Thr-Glu-Tyr motif. Mol. Hum. Reprod.11, 211–221 (2005).
   PubMed Web of Science ®Google Scholar
• Chaturverdi D, Poppleton HM, Stringfield T, Barbier A, Patel TB. Subcellular localization and biological actions of activated RSK1 are determined by its interactions with subunits of cyclic AMP-dependent protein kinase. Mol. Cell. Biol.26, 4586–4600 (2006).
   PubMed Web of Science ®Google Scholar
• Noda T, Ohsumi Y. TOR, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem.273, 3963–3966 (1998).
   PubMed Web of Science ®Google Scholar
• Kim J, Huang WP, Stromhaug PE, Klionsky DJ. Convergence of multiple autophagy and cytoplasm to vacuole targeting components to a perivacuolar membrane compartment prior to de novo vesicle formation. J. Biol. Chem.277, 763–773 (2002).
   PubMed Web of Science ®Google Scholar
• Suzuki K, Kirisako T, Kamada Y, Mizushima N, Noda T, Ohsumi Y. The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J.20, 5971–5981 (2001).
   PubMed Web of Science ®Google Scholar
• Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell.124, 471–484 (2006).
   PubMed Web of Science ®Google Scholar
• Mavrakis M, Lippincott-Schwartz J, Stratakis CA, Bossis I. Depletion of type IA regulatory subunit (RIα) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency. Hum. Mol. Genet.15, 2962–2971 (2006).
   PubMed Web of Science ®Google Scholar
• Haddox MK, Roeske WR, Russell DH. Independent expression of cardiac type I and II cyclic AMP-dependent protein kinase during murine embryogenesis and postnatal development. Biochim. Biophys. Acta585, 527–534 (1979).
   PubMed Web of Science ®Google Scholar
• Malkinson AM, Hogy L, Gharrett AJ, Gunderson TJ. Ontogenic studies of cyclic AMP-dependent protein kinase enzymes from mouse heart and other tissues. J. Exp. Zool.205, 423–432 (1978).
   PubMedGoogle Scholar
• Skalhegg BS, Landmark BF, Døskeland SO, Hansson V, Lea T, Jahnsen T. Cyclic AMP-dependent protein kinase type I mediates the inhibitory effect of 3´,5´-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J. Biol. Chem.267, 15707–15714 (1992).
   PubMed Web of Science ®Google Scholar
• Tasken K, Hansson V, Aukrust P et al. PKAI as a potential target for therapeutic intervention. Drug News Perspect.13, 12–18 (2000).
   PubMedGoogle Scholar
• Laxminarayana D, Kammer GM. mRNA mutations of type I protein kinase A regulatory subunit α in T lymphocytes as a subject with systemic lupus erythematosus. Int. Immunol.12, 1521–1529 (2000)
   PubMed Web of Science ®Google Scholar
• Khan IU, Laxminarayana D, Kammer GM. Protein kinase A RI β subunit deficiency in lupus T lymphocytes: bypassing a block in RI β translation reconstitutes protein kinase A activity and augments IL-2 production. J. Immunol.166, 7600–7605 (2001).
   PubMed Web of Science ®Google Scholar
• Lania A, Mantovani G, Ferrero S et al. Proliferation of transformed somatotroph cells related to low or absent expression of PKA regulatory subunit 1A protein. Cancer Res.64, 9193–9198 (2004).
   PubMed Web of Science ®Google Scholar
• Griffin KJ, Kirschner LS, Matyakhina L et al. Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Res.64, 8811–8815 (2004).
   PubMed Web of Science ®Google Scholar
• Deppert W. Mutant p53: from guardian to fallen angel? Oncogene26, 2142–2144 (2007).
   PubMed Web of Science ®Google Scholar
• Cho-Chung YS, Nesterova MV. Tumor reversion: protein kinase A isozyme switching. Ann. NY Acad. Sci.1058, 76–86 (2005).
   PubMed Web of Science ®Google Scholar
• Tortora G, Ciardiello F. Antisense targeting protein kinase A Type I as a drug for integrated strategies of cancer therapy. Ann. NY Acad. Sci.1002, 236–243 (2003).
   PubMed Web of Science ®Google Scholar